{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:00:03Z","timestamp":1787022003479,"version":"build-2736575974"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T00:00:00Z","timestamp":1496361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Australian Companion Animal Health Foundation","award":["009\/15"],"award-info":[{"award-number":["009\/15"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178783","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T13:50:45Z","timestamp":1496411445000},"page":"e0178783","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats"],"prefix":"10.1371","volume":"12","author":[{"given":"Jana","family":"Leshinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J. R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6761-8022","authenticated-orcid":true,"given":"Vanessa R.","family":"Barrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,2]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"e64871","DOI":"10.1371\/journal.pone.0064871","article-title":"Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs","volume":"8","author":"VR Barrs","year":"2013","journal-title":"PLOS ONE"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/599345","article-title":"Invasive aspergillosis due to Neosartorya udagawae","volume":"49","author":"DC Vinh","year":"2009","journal-title":"Clinical infectious diseases"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/JCM.01704-14","article-title":"Genetic relatedness versus biological compatibility between Aspergillus fumigatus and related species","volume":"52","author":"JA Sugui","year":"2014","journal-title":"Journal of clinical microbiology"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tvjl.2011.02.009","article-title":"Sinonasal and sino-orbital aspergillosis in 23 cats: aetiology, clinicopathological features and treatment outcomes","volume":"191","author":"VR Barrs","year":"2012","journal-title":"Veterinary journal (London, England: 1997)"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1517\/13543784.10.8.1545","article-title":"Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections","volume":"10","author":"AH Groll","year":"2001","journal-title":"Expert opinion on investigational drugs"},{"key":"ref6","article-title":"Seminars in Respiratory and critical care medicine","author":"CA Kauffman","year":"2008"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1592\/phco.24.14.1408.43148","article-title":"Caspofungin: a potential cause of reversible severe thrombocytopenia","volume":"24","author":"J Lynch","year":"2004","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"issue":"14","key":"ref8","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.2165\/00003495-200565140-00009","article-title":"Caspofungin: a review of its use in the treament of fungal infections","volume":"65","author":"PL McCormack","year":"2005","journal-title":"Drugs"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"W Meersseman","year":"2004","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","article-title":"Resistance to echinocandin-class antifungal drugs","volume":"10","author":"DS Perlin","year":"2007","journal-title":"Drug Resistance Updates"},{"key":"ref11","first-page":"263","article-title":"Aspergillosis: From Diagnosis to Prevention","author":"DS Perlin","year":"2010"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1517\/13543784.12.8.1313","article-title":"The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy","volume":"12","author":"NP Wiederhold","year":"2003","journal-title":"Expert opinion on investigational drugs"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/AAC.45.2.596-600.2001","article-title":"Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits","volume":"45","author":"AH Groll","year":"2001","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1128\/AAC.41.11.2339","article-title":"Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)","volume":"41","author":"R Hajdu","year":"1997","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"Supplement1","key":"ref15","first-page":"74","article-title":"Pharmacokinetics of the antifungal drug micafungin in mice, rats and dogs, and its in vitro protein binding and distribution to blood cells","volume":"50","author":"Y Yamato","year":"2002","journal-title":"Japanese Journal of Chemotherapy"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008571-199804000-00009","article-title":"Deficiency of cytosolic arylamine N-acetylation in the domestic cat and wild felids caused by the presence of a single NAT1-like gene","volume":"8","author":"L Trepanier","year":"1998","journal-title":"Pharmacogenetics"},{"key":"ref17","article-title":"NONMEM 7.3. 0 Users Guides","author":"S Beal","year":"1989"},{"key":"ref18","unstructured":"Schloerke B, Crowley J, Cook D, Hofmann H, Wickham H, Briatte F, et al. Ggally: Extension to ggplot2. R package version 0.5. 0. http:\/\/cranr-projectorg\/web\/packages\/GGally\/indexhtml<\/ext-link>. 2014."},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-98141-3","article-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2009"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v040.i01","article-title":"The split-apply-combine strategy for data analysis","volume":"40","author":"H Wickham","year":"2011","journal-title":"Journal of Statistical Software"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v021.i12","article-title":"Reshaping data with the reshape package","volume":"21","author":"H Wickham","year":"2007","journal-title":"Journal of Statistical Software"},{"key":"ref22","unstructured":"Wickham H. scales: Scale functions for graphics. 2014."},{"key":"ref23","article-title":"stringr: Make it easier to work with strings","volume":"2","author":"H Wickham","year":"2012","journal-title":"R package version 06"},{"key":"ref24","unstructured":"Wickham H. Easily Tidy Data with'spread ()'and \u201cgather ()\u201d Functions. CRAN R Package http:\/\/cran\/R-projectorg\/package=tidyr<\/ext-link> version 041. 2016."},{"key":"ref25","article-title":"gridExtra: functions in Grid graphics","volume":"1","author":"B Auguie","year":"2012","journal-title":"R package version 09"},{"key":"ref26","unstructured":"Harrell Jr FE. Hmisc: Harrell Miscellaneous (Version 3.14\u20134)[Computer program, R package]. Nashville, TN: Author Retrieved from CRAN R-project org\/package = Hmisc. 2014."},{"key":"ref27","first-page":"5","article-title":"doBy: Groupwise statistics, LSmeans, linear contrasts, utilities","volume":"4","author":"S H\u00f8jsgaard","year":"2014","journal-title":"R package version"},{"key":"ref28","article-title":"R: A language and environment for statistical computing","year":"2013"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1086\/424465","article-title":"Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity","volume":"190","author":"NP Wiederhold","year":"2004","journal-title":"Journal of Infectious Diseases"},{"key":"ref30","article-title":"Wild-Type MIC Distributions and Epidemiological Cutoff Values for Caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 document)","author":"A Espinel-Ingroff","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1128\/JCM.00134-11","article-title":"Uncommon Neosartorya udagawae Fungus as a Causative Agent of Severe Corneal Infection","volume":"49","author":"B Posteraro","year":"2011","journal-title":"Journal of Clinical Microbiology"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1128\/EC.00162-06","article-title":"Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping","volume":"5","author":"SA Balajee","year":"2006","journal-title":"Eukaryotic Cell"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1128\/AAC.48.3.815-823.2004","article-title":"Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma","volume":"48","author":"JA Stone","year":"2004","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0090-9556(24)15072-6","article-title":"Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine","volume":"28","author":"SK Balani","year":"2000","journal-title":"Drug metabolism and disposition"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/0091270007303764","article-title":"Single-and Multiple-Dose Administration of Caspofungin in Patients With Hepatic Insufficiency: Implications for Safety and Dosing Recommendations","volume":"47","author":"GC Mistry","year":"2007","journal-title":"The Journal of Clinical Pharmacology"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/AAC.46.3.739-745.2002","article-title":"Single-and multiple-dose pharmacokinetics of caspofungin in healthy men","volume":"46","author":"JA Stone","year":"2002","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1074-7613(03)00233-4","article-title":"Fungal \u03b2-glucans and mammalian immunity","volume":"19","author":"GD Brown","year":"2003","journal-title":"Immunity"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1128\/AAC.45.10.2845-2855.2001","article-title":"Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling","volume":"45","author":"AH Groll","year":"2001","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"25","key":"ref39","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"J Mora-Duarte","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1592\/phco.23.8.966.32875","article-title":"Effects of amphotericin B and caspofungin on histamine expression","volume":"23","author":"JD Cleary","year":"2003","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/vec.12066","article-title":"Anaphylaxis in dogs and cats","volume":"23","author":"DL Shmuel","year":"2013","journal-title":"Journal of Veterinary Emergency and Critical Care"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1751-0813.2006.tb12768.x","article-title":"Physiological and haematological findings and clinical observations in a model of acute systemic anaphylaxis in Dirofilaria immitis-sensitised cats","volume":"84","author":"A Litster","year":"2006","journal-title":"Australian veterinary journal"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1476-5381.1978.tb17320.x","article-title":"Responses of the simultaneously-perfused hepatic arterial and portal venous vascular beds of the dog to histamine and 5-hydroxytryptamine","volume":"64","author":"P Richardson","year":"1978","journal-title":"British journal of pharmacology"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/path.1700270106","article-title":"The morbid anatomy and histology of anaphylaxis in the dog","volume":"27","author":"H Dean","year":"1924","journal-title":"The Journal of Pathology and Bacteriology"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1476-4431.2009.00474.x","article-title":"Elevation of alanine transaminase and gallbladder wall abnormalities as biomarkers of anaphylaxis in canine hypersensitivity patients","volume":"19","author":"JE Quantz","year":"2009","journal-title":"Journal of Veterinary Emergency and Critical Care"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"G472","DOI":"10.1152\/ajpgi.1987.252.4.G472","article-title":"Effect of histamine, norepinephrine, and nerves on vascular pressures in dog liver","volume":"252","author":"WW Lautt","year":"1987","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1081-1206(10)60714-4","article-title":"Fatal anaphylaxis: postmortem findings and associated comorbid diseases","volume":"98","author":"PA Greenberger","year":"2007","journal-title":"Annals of allergy, asthma & immunology"},{"key":"ref48","first-page":"98","article-title":"Anaphylaxis","volume":"95","author":"A Genovese","year":"2010"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/jac\/dkn069","article-title":"Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis","volume":"61","author":"RE Lewis","year":"2008","journal-title":"Journal of antimicrobial chemotherapy"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/AAC.46.1.12-23.2002","article-title":"Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia","volume":"46","author":"R Petraitiene","year":"2002","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"11","key":"ref51","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/AAC.42.11.2898","article-title":"Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits","volume":"42","author":"V Petraitis","year":"1998","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1128\/AAC.48.4.1272-1280.2004","article-title":"Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys","volume":"48","author":"P Sandhu","year":"2004","journal-title":"Antimicrobial agents and chemotherapy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:15:17Z","timestamp":1750274117000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178783"}},"subtitle":[],"editor":[{"given":"Douglas","family":"Thamm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,2]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178783","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,2]]}}}